Community Research and Development Information Service - CORDIS

Results 1 - 10 of 73
Order by: Results/page:
12 3 4 5 6 7 8 > 
New Medicines for Trypanosomatidic Infections
ID: 603240
Start date: 2014-02-01, End date: 2017-01-31
The infectious diseases burden imposed by the parasites of Trypanosomatidae family represents a huge problem on people’s lives in countries where these diseases are endemic. Problems associated with existing drugs include inefficient delivery, insufficient efficacy, excessive...
Programme: FP7-HEALTH
Record Number: 109924
Last updated on: 2018-01-03
European Consortium for the Study of a Topical Treatment of  iCRVO to prevent Neovascular Glaucoma
ID: 305321
Start date: 2012-10-01, End date: 2018-03-31
Neovascular glaucoma (NVG) is a very aggressive and rare type of glaucoma: yet, it contributes disproportionately to blindness from all eye diseases. NVG is also the second most common cause for the removal of the eye-ball across all eye diseases, usually because of intractab...
Programme: FP7-HEALTH
Record Number: 105416
Last updated on: 2018-01-03
Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders
ID: 602186
Start date: 2013-11-01, End date: 2018-10-31
Our proposal is based on the idea that real-time functional neuroimaging can be used to train patients to regulate their own brain activity via neurofeedback training and thus modulate the brain networks of mental disorder, restore function, improve symptoms and promote resil...
Programme: FP7-HEALTH
Record Number: 109338
Last updated on: 2017-12-11
New Technologies and Production Tools for Complex Protein Biologics
ID: 279039
Start date: 2011-11-01, End date: 2015-10-31
ComplexINC conceptualizes and systematically generates advanced tool-kits to enable high-throughput assembly of complex biologics and metabolic pathways in eukaryotic expression systems, for micro- to large scale production of high-quality protein specimens for drug discovery...
Programme: FP7-HEALTH
Record Number: 102213
Last updated on: 2017-12-11
High-throughput peptidomics and transcriptomics of animal venoms for discovery of novel therapeutic peptides and innovative drug development
ID: 278346
Start date: 2011-11-01, End date: 2015-10-31
Animal venoms are complex cocktails of peptides that have enormous potential as novel therapeutic leads. Replicating in vitro the diversity of venoms by generating large synthetic combinatorial peptide libraries will solve the challenge of working with limited amounts of natu...
Programme: FP7-HEALTH
Record Number: 101790
Last updated on: 2017-12-11
Point-of-care tests to revolutionise the clinical management of patients infected by Hepatitis C virus
ID: 601851
Start date: 2013-09-01, End date: 2016-08-31
Point-of-care (PoC) medical devices have the potential to revolutionise clinical practice. SMEs within our Consortium (Epistem & Biosurfit) have developed genetic and protein PoC devices to deliver on this promise. Results from these enabling technologies will be integrated u...
Programme: FP7-HEALTH
Record Number: 108767
Last updated on: 2017-11-20
Social innovation to improve physical activity and sedentary behaviour through elite European football clubs:  European Fans in Training
ID: 602170
Start date: 2013-11-01, End date: 2018-10-31
Concept and aim: 20 million fans attend top division football games each week and many more watch on TV. Our social innovation is to attract people to lifestyle change through the personal connection and loyalty to the club they support. Our aim is to use this social innovati...
Programme: FP7-HEALTH
Record Number: 109459
Last updated on: 2017-11-20
Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas diseasE
ID: 305937
Start date: 2012-09-01, End date: 2018-08-31
The BERENICE consortium is aiming at providing a new and cost-effective solution to a better treatment for Chagas chronic patients. Please see its objectives below : Main objective • Obtain a more effective, better tolerated and cheaper formulation of a drug with trypanocidal...
Programme: FP7-HEALTH
Record Number: 106038
Last updated on: 2017-10-06
International study for treatment of childhood relapsed ALL 2010 with standard therapy, systematic integration of new agents, and establishment of standardized diagnostic and research
ID: 278514
Start date: 2011-10-01, End date: 2017-09-30
Though survival of children with acute lymphoblastic leukaemia (ALL) has improved, relapse remains a leading cause of mortality in childhood cancer. Given the rarity of the disease, only a large international cooperative group can recruit sufficient patients for prospective s...
Programme: FP7-HEALTH
Record Number: 102104
Last updated on: 2017-09-03
Novel approaches for prevention and degeneration of pathogenic bacteria biofilms formed on medical devices e.g. catheters
ID: 278402
Start date: 2012-01-01, End date: 2014-12-31
Biofilms are bacterial communities encased in a self-produced hydrated polymeric matrix. An important characteristic of microbial biofilms is their innate resistance to the immune system and susceptibility to antibiotics. This resistance has made microbial biofilms a common c...
Programme: FP7-HEALTH
Record Number: 101792
Last updated on: 2017-09-03
12 3 4 5 6 7 8 > 
List retrieved on: 2018-02-22
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top